Overview

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Status:
Recruiting

Trial end date:
2025-08-01

Target enrollment:

Participant gender:

Summary

This single-arm, open, multicenter clinical study is going to evaluate the efficacy and safety of combination therapy with ectiecinib, pemetrexed and platinum in patients with metastatic non-squamous non-small cell lung cancer with EGFR mutations who did not progress after pemetrexed in combination with platinum-based chemotherapy.

Phase:

Phase 3

Details

Lead Sponsor:

Tianjin Medical University Cancer Institute and Hospital

Treatments:

Pemetrexed